Can Anyone Get Ozempic for Weight Loss?

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has gained widespread attention for weight loss outcomes—with clinical trials showing average weight reductions of 10 to 15% of body weight over 68 weeks. However, not everyone qualifies for this medication, and access depends on several individual health factors and your prescriber's clinical judgment. PlexusDx connects patients with licensed providers who evaluate candidacy and offer compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance requirement.

Medical Eligibility Requirements for Semaglutide Therapy

Semaglutide candidates typically have a BMI of 30 or higher (obese category) or a BMI of 27 to 29.9 with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or sleep apnea. Your prescriber will review your complete medical history, current medications, and any past reactions to GLP-1 drugs to determine if semaglutide is appropriate for your situation. Age, baseline kidney function, and prior gastrointestinal surgery may also influence whether your provider recommends this medication.

Individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2) should not use semaglutide due to animal study findings. Pregnancy, breastfeeding, or plans to conceive within the next three months are contraindications, since GLP-1 agonists have not been adequately studied in these populations. If you have diabetic retinopathy or severe pancreatitis history, your prescriber will weigh risks and benefits before recommending treatment.

Why Some Patients Don't Qualify for GLP-1 Medications

Cost and access barriers historically limited semaglutide to insured patients or those who could afford brand-name Ozempic at retail prices exceeding $900 monthly. Many primary care providers lack expertise in GLP-1 dosing and side effect management, resulting in fewer referrals for weight loss therapy. Insurance companies often impose strict prior authorization requirements, including documented diet-and-exercise failure or mandatory trial of older medications, delaying or denying treatment.

Medical contraindications also restrict eligibility: patients with active pancreatitis, uncontrolled thyroid disease, or severe kidney impairment (eGFR below 15) may not be candidates. Those taking certain medications that interact with semaglutide, such as insulin secretagogues without dose adjustment, require specialist consultation. PlexusDx removes access barriers by offering compounded semaglutide through licensed 503A pharmacies, serving patients in all 50 states without membership fees or insurance requirements.

Compounded vs. Brand-Name Semaglutide: Access and Affordability

Brand-name Ozempic costs $900 to $1,350 per month without insurance coverage, placing it out of reach for millions of Americans despite clinical evidence supporting its weight loss benefit. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan—a fraction of brand-name pricing—while maintaining the same active compound prepared by licensed 503A compounding pharmacies under strict federal quality standards. This pricing model removes cost as a barrier to starting therapy, allowing more patients who meet medical criteria to access evidence-based treatment.

Compounded medications are prescribed by licensed healthcare providers and dispensed by pharmacies operating under federal oversight; they are not FDA-approved but are legally prescribed off-label for weight loss when clinically indicated. Patients should confirm their pharmacy maintains proper licensure and sterility protocols, which PlexusDx ensures through partnerships with accredited 503A facilities. HSA and FSA accounts cover PlexusDx medications, further reducing out-of-pocket costs for eligible patients.

Personalized Treatment Through Genetic Insights

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with specific genetic markers showing lower GLP-1 pathway activation may benefit from tirzepatide (a dual GLP-1/GIP agonist) or combination therapy, while others respond robustly to semaglutide monotherapy. Genetic testing helps explain why two patients on identical semaglutide doses experience different weight loss trajectories and hunger suppression effects. By integrating genetic data into your treatment plan, PlexusDx enables truly personalized weight loss therapy rather than one-size-fits-all dosing.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the minimum BMI to qualify for semaglutide through PlexusDx?

PlexusDx providers typically recommend semaglutide for patients with a BMI of 30 or higher, or BMI of 27 to 29.9 with weight-related conditions like hypertension or type 2 diabetes. Your prescriber will evaluate your individual health profile and medical history to determine if you meet clinical criteria for treatment.

How much weight can I expect to lose on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I get semaglutide without insurance through PlexusDx?

Yes. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance requirement, no membership fee, and no prior authorization delays. Patients can pay monthly, and HSA or FSA funds are eligible for coverage.

What are the most common side effects of semaglutide?

Nausea, vomiting, diarrhea, and constipation occur in 20 to 60% of patients during dose escalation and typically subside within weeks. Rare but serious risks include acute pancreatitis, severe allergic reactions, and thyroid concerns—which is why your PlexusDx provider conducts thorough screening before starting therapy and monitors you throughout treatment.

How does the Precision Peptide Genetic Test help with semaglutide treatment?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.